factually
Index/Topics/Oncology Trials

Oncology Trials

Clinical trials for cancer treatment

Fact-Checks

3 results
Jan 18, 2026
Most Viewed

Have any completed human studies reported safety or pharmacokinetics of high‑dose ivermectin in cancer patients?

No completed human studies specifically reporting the safety or pharmacokinetics (PK) of high‑dose ivermectin in cancer patients have been published in the sources provided; the literature instead con...

Jan 24, 2026
Most Viewed

How do Phase 1, Phase 2 and Phase 3 oncology trials differ in what they can prove about safety and efficacy?

occupy distinct roles in the evidence ladder: Phase 1 primarily establishes safety, tolerability and a recommended dose; Phase 2 tests for signs of anti‑tumor activity and refines safety in the target...

Jan 15, 2026
Most Viewed

What specific adverse events (organ systems, grades) have randomized trials of ivermectin reported, and how consistent are their definitions across studies?

Randomized trials of ivermectin for COVID-19 and other indications report adverse events spanning neurological, gastrointestinal, dermatologic, ocular, and systemic (including multiorgan failure) cate...